Recursion Pharmaceuticals
Salt Lake City, Utah, United States · Artificial Intelligence, Biotechnology, Healthcare
Recursion Pharmaceuticals, Inc. is a biotechnology company that leverages advanced technology to discover and develop potential new drugs. The company focuses on therapeutics in disease areas with significant unmet medical need. Through its innovative platform, Recursion aims to transform the process of drug discovery. With a commitment to improving patient outcomes, the company is at the forefron
Key facts
- Headquarters
- Salt Lake City, Utah, United States
- Employees
- 800
- Industries
- Artificial Intelligence, Biotechnology, Healthcare
- Status
- Public (RXRX)
- Website
- www.recursion.com
- Company page
Recent activity at Recursion Pharmaceuticals
- : Recursion Pharmaceuticals Raises $200 Million Through Share Offering
- : Recursion Pharmaceuticals Appoints Vicki Goodman, M.D., as Chief Medical Officer
- : Recursion Appoints Vicki Goodman as Chief Medical Officer
- : Recursion Pharmaceuticals Registers Shares for Resale in Tempus Agreement
- : Recursion Pharmaceuticals Expands AI Partnerships and Acquires Exscientia to Enhance Drug Discovery Capabilities.
- : Recursion and Exscientia Partner to Create Trans-Atlantic AI Powerhouse for Drug Development
- : Recursion and Google Cloud Expand Partnership to Support Drug Discovery and Exploration of Generative AI Technologies
- : Recursion Pharmaceuticals Appoints Najat Khan as Chief Commercial Officer and Head of R&D
- : RECURSION PHARMACEUTICALS, INC.
- : RECURSION PHARMACEUTICALS, INC.
Recursion Pharmaceuticals funding history
| Date | Round | Amount |
|---|---|---|
| Oct 2026 | Post-IPO Equity | $200.0M |
| Sep 2020 | Venture | $235.5M |
| Aug 2019 | Venture | $122.1M |
| Oct 2017 | Venture | $55.8M |
| Sep 2016 | Venture | $32.0M |
Leadership
- CHRISTOPHER GIBSON, Executive Officer, Director, Promoter
- BLAKE BORGESON, Director
- ZAVAIN DAR, Director
- ZACHARY BOGUE, Director
- DEAN LI, Director
- ROBERT HERSHBERG, Director
- TERRY-ANN BURRELL, Director
- R. CHAVEZ, Director
Verified email and direct lines for Recursion Pharmaceuticals’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Recursion Pharmaceuticals files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Companies similar to Recursion Pharmaceuticals
- Apellis Pharmaceuticals · Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
- Madrigal Pharmaceuticals · Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
- Crinetics Pharmaceuticals · Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
- Amylyx Pharmaceuticals · Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
- Parabilis Medicines · Biotechnology, Healthcare, Health Care, Pharmaceutical, Therapeutics
About Recursion Pharmaceuticals: questions and answers
What does Recursion Pharmaceuticals do?
Recursion Pharmaceuticals, Inc. is a biotechnology company that leverages advanced technology to discover and develop potential new drugs. The company focuses on therapeutics in disease areas with significant unmet medical need. Through its innovative platform, Recursion aims to transform the process of drug discovery. With a commitment to improving patient outcomes, the company is at the forefron
Where is Recursion Pharmaceuticals headquartered?
Recursion Pharmaceuticals is headquartered in Salt Lake City, Utah, United States.
How many employees does Recursion Pharmaceuticals have?
Recursion Pharmaceuticals has about 800 employees.
Has Recursion Pharmaceuticals raised funding?
Yes. Fundz has recorded 5 funding events for Recursion Pharmaceuticals. The most recent, Post-IPO Equity of $200.0M, was in Oct 2026.
What is the latest news on Recursion Pharmaceuticals?
On Oct 15, 2026, Recursion Pharmaceuticals Raises $200 Million Through Share Offering
Is Recursion Pharmaceuticals a public company?
Yes. Recursion Pharmaceuticals is publicly traded under the ticker RXRX.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy